Latest News about Stories That Matter
Recent news which mentions Stories That Matter
'Culture Is Not Something You Can Buy': Why Genuine Engagement Matters In Cannabis
November 20, 2024
Tickers
CCC
From Benzinga
'Struggle, Resiliency And A Positive Future': The Road Ahead for California's Cannabis Market
November 20, 2024
From Benzinga
Bitcoin Holding On To $94,000, Ethereum, Dogecoin Trade Lower: 'Place Your Bets, Up Or Down Brothers,' Says Trader
November 20, 2024
From Benzinga
DraftKings Analyst Sees Sports Betting Sector Growth, Positive Outcome From Paul Vs. Tyson Fight
November 20, 2024
From Benzinga
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
November 20, 2024
From Benzinga
Bitcoin To '$100,000 Is 'Programmed:' Dogecoin, Bonk To Benefit, Veteran Trader Says
November 20, 2024
From Benzinga
Roaring Kitty Ditched Chewy, Analyst Says You Should Adopt The Stock With 'Path To Pawsitive Growth'
November 20, 2024
Tickers
CHWY
From Benzinga
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Walmart Posts Q3 Sales Beat, Raises Guidance: Analysts Expect Strong Earnings Growth Ahead
November 20, 2024
Tickers
WMT
From Benzinga
Fed's Bowman Warns On Inflation, Says Neutral Interest Rates May Be Closer 'Than We Currently Think'
November 20, 2024
From Benzinga
Muddy Waters' Carson Block Bets Against E.L.F. Beauty: Short Seller Says Retailer's Financials Show 'Major Red Flag'
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
November 20, 2024
From Benzinga
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
November 20, 2024
From Benzinga
CrowdStrike, Nasdaq, D.R. Horton And More On CNBC's 'Final Trades'
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
Microsoft 'One Of The Most Compelling Investment Opportunities,' Says Goldman Sachs
November 20, 2024
From Benzinga
From Benzinga
WeRide's Robotaxi And Partnerships Are Key Growth Drivers For Global Expansion: Analyst
November 20, 2024
From Benzinga
What's Going On With C3.ai Stock Wednesday?
November 20, 2024
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
Mullen Lands Big Wins With California Universities: Details
November 20, 2024
From Benzinga
4 Reasons Why Ethereum Will Still Outperform Bitcoin—Analyst Sees $4,000 To $6,000 As Target
November 20, 2024
From Benzinga
From Benzinga
Can Baidu Break Bearish Spell? Buying Pressure Shows Bullish Pre-Earnings Potential
November 20, 2024
From Benzinga
What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?
November 20, 2024
From Benzinga
Nvidia Stock Historically Drops In December After Q3 Earnings
November 20, 2024
From Benzinga
Stock Of The Day: Delta Air Lines Bullish Pattern Suggests Upside Ahead
November 20, 2024
Tickers
DAL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.